Shoe-stiffening inserts for first metatarsophalangeal joint osteoarthritis (the SIMPLE trial): study protocol for a randomised controlled trial
journal contributionposted on 26.05.2021, 06:14 by Shannon Munteanu, Karl Landorf, Jodie McClelland, Edward Roddy, Flavia M Cicuttini, Alan Shiell, Maria Auhl, Jamie Allan, Andrew Buldt, Hylton Menz
Background: This article describes the design of a parallel-group, participant- and assessor-blinded randomised controlled trial comparing the effectiveness of shoe-stiffening inserts versus sham shoe insert(s) for reducing pain associated with first metatarsophalangeal joint (MTPJ) osteoarthritis (OA). Methods: Ninety participants with first MTPJ OA will be randomised to receive full-length shoe-stiffening insert(s) (Carbon Fibre Spring Plate, Paris Orthotics, Vancouver, BC, Canada) plus rehabilitation therapy or sham shoe insert(s) plus rehabilitation therapy. Outcome measures will be obtained at baseline, 4, 12, 24 and 52 weeks; the primary endpoint for assessing effectiveness being 12 weeks. The primary outcome measure will be the foot pain domain of the Foot Health Status Questionnaire (FHSQ). Secondary outcome measures will include the function domain of the FHSQ, severity of first MTPJ pain (using a 100-mm Visual Analogue Scale), global change in symptoms (using a 15-point Likert scale), health status (using the Short-Form-12® Version 2.0 and EuroQol (EQ-5D-5L™) questionnaires), use of rescue medication and co-interventions, self-reported adverse events and physical activity levels (using the Incidental and Planned Activity Questionnaire). Data will be analysed using the intention-to-treat principle. Economic analysis (cost-effectiveness and cost-utility) will also be performed. In addition, the kinematic effects of the interventions will be examined at 1 week using a three-dimensional motion analysis system and multisegment foot model. Discussion: This study will determine whether shoe-stiffening inserts are a cost-effective intervention for relieving pain associated with first MTPJ OA. The biomechanical analysis will provide useful insights into the mechanism of action of the shoe-stiffening inserts. Trial registration: Australian New Zealand Clinical Trials Registry, identifier: ACTRN12616000552482. Registered on 28 April 2016.
Pagination13p. (p. 1-13)
Rights StatementThe Author reserves all moral rights over the deposited text and must be credited if any re-use occurs. Documents deposited in OPAL are the Open Access versions of outputs published elsewhere. Changes resulting from the publishing process may therefore not be reflected in this document. The final published version may be obtained via the publisher’s DOI. Please note that additional copyright and access restrictions may apply to the published version.
Science & TechnologyLife Sciences & BiomedicineMedicine, Research & ExperimentalResearch & Experimental MedicineOsteoarthritisMetatarsophalangeal jointHallux rigidusFoot orthosesHEALTH-STATUS QUESTIONNAIREMANCHESTER FOOT PAINDISABILITY INDEXHALLUX LIMITUSOLDER-PEOPLEORTHOSESRECOMMENDATIONSVALIDATIONKINEMATICSCLASSIFICATIONMetatarsophalangeal JointHumansClinical ProtocolsPatient ComplianceShoesCost-Benefit AnalysisFoot OrthosesBiomechanical PhenomenaOutcome Assessment, Health CareCardiovascular System & HematologyGeneral & Internal Medicine